Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Tetanus booster

Vaccine (Recombinant protein vaccine) · Immune activation

Phase 1/2 Most advanced trial (none active)

What is Tetanus booster?

Tetanus booster (Td) is a tetanus and diphtheria toxoid combination given at 5 flocculation units (Lf) of the tetanus component.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Td booster
Drug type
Vaccine (Recombinant protein vaccine)
Mechanism
Immune activation
Therapy area
Oncology
In trials of
BMY
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 1/2

Conditions studied

Diffuse Midline GliomaDiffuse Midline High-grade GliomaEpendymomaMedulloblastoma

Sources

Updated Nov 8, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.